Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting120%
completed360%
not_yet_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
completed

Sleep State in Lung Cancer: A Retrospective Analysis

NCT06953492
not_yet_recruiting

A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer

NCT06953765
recruiting

Sleep Disorders and Tumor Immune Microenvironment

NCT06941948
completednot_applicable

Objective Sleep Behavior in Relation to a Nigth Competition in Athletes.

NCT03773601
completed

Sleep Quality Among HCWs

NCT04549350

Clinical Trials (5)

Showing 5 of 5 trials
NCT06953492

Sleep State in Lung Cancer: A Retrospective Analysis

Completed
NCT06953765

A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer

Not Yet Recruiting
NCT06941948

Sleep Disorders and Tumor Immune Microenvironment

Recruiting
NCT03773601Not Applicable

Objective Sleep Behavior in Relation to a Nigth Competition in Athletes.

Completed
NCT04549350

Sleep Quality Among HCWs

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5